Navigation Links
Beyond the Nobel Prize, what's next for graphene?
Date:10/13/2010

If you had never heard of "graphene" before, you might know something about it now if you've followed the 2010 Nobel Prize announcements. Two physicists at the University of Manchester (UK) were awarded the Nobel Prize in Physics "for groundbreaking experiments regarding the two-dimensional material graphene," carbon flakes that are only as thick as a single atom yet as strong as steel and as conductive as copper. But, what happens next for this revolutionary nanoscale material? Two social scientists began a study earlier in 2010 to understand the as yet undeveloped pathway to the commercialization of graphene the processes, plans, promises and perils. Team leaders with the Center for Nanotechnology in Society at Arizona State University (CNS-ASU), Jan Youtie at Georgia Institute of Technology (Georgia Tech) and Philip Shapira at the University of Manchester and Georgia Tech are in the throes of their project on the Comparative Research and Innovation Approaches of Graphene Centers.

Graphene is anticipated to have potential applications in electronics to build semiconductors beyond the limits of silicon-based technology. It also offers promising applications for higher performance solar cells, LCD screens and photon sensors. Now that graphene has been identified and found to be stable in ultra-thin sheets, research efforts to understand it more thoroughly and to produce it in large quantities have ballooned. Yet, graphene is still at the development stage, and its commercialization pathway remains to be determined.

To kick-off their work on graphene innovation, Youtie and Shapira have been undertaking field work in two of the world's leading centers for graphene development: the University of Manchester and Georgia Tech. As acknowledged by the Nobel Committee for Physics when it awarded its 2010 Prize to Manchester physicists Andre Geim and Konstantin Novoselov, Manchester is the site of seminal work on graphene, including the first laboratory production of graphene sheets. Georgia Tech is the site of a National Science Foundation-funded Materials Science and Engineering Center (MRSEC) focused on research and development on epitaxial graphene. Youtie's and Shapira's project seeks to understand similarities and differences in the plans, programs and approaches to commercialize graphene-related applications in both locations. This includes examination of both the strategies for research and development and those for fostering commercialization in terms of external partnerships in the metropolitan regions of Manchester and Atlanta, elsewhere in the country, and internationally. In addition to field work, Youtie and Shapira also are undertaking analyses of publications, patents, funding, and corporate activities in graphene.

Over the coming year, Youtie and Shapira plan to expand their research focus to other locations in the United States and around the world where graphene research and commercialization clusters are emerging. Although graphene's full impacts may take many years to materialize, the results of Youtie's and Shapira's research will provide real-time insights to researchers, companies, policymakers and other stakeholders keen to understand how research in specific nanotechnology domains moves into early applications, what barriers and concerns are raised, and how these are being addressed.


'/>"/>

Contact: Cathy Arnold
cathy.arnold@asu.edu
480-965-0555
Arizona State University
Source:Eurekalert

Related biology technology :

1. Webinar Alert: Managing Paper at Its Roots: Extending Beyond Document Management to Enterprise Content Compliance
2. Beyond Turbidity: Selecting Appropriate Technology for in Situ Monitoring and Control of Complex Particle and Droplet Systems
3. Caturano and Company to Host Boston Biotech Event, "BIBA Biotech 2010 and Beyond"
4. Life Beyond Cancer Foundation Adds Bob Ingram to its Board of Directors
5. Beyond associations: Colorectal cancer culprit found
6. Informex Survey Shows Innovation Remains a Priority for 2009 and Beyond
7. Dow AgroSciences Delivering Beyond Expectations
8. Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM)
9. Far From Beyond: A Glimpse into the World of Biotechnology and the Future of the Free World
10. Nobel Spotlight on IVF Boosts Family Building Procedures
11. California IVF Pioneer Donald Galen, M.D., Trained With Nobel Winner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):